Point72 Hong Kong’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-16,377
| Closed | -$3.5M | – | 1470 |
|
|
2022
Q2 | $3.5M | Buy |
16,377
+14,089
| +616% | +$3.01M | 0.13% | 131 |
|
|
2022
Q1 | $650K | Buy |
2,288
+1,521
| +198% | +$432K | 0.02% | 274 |
|
|
2021
Q4 | $289K | Buy |
767
+516
| +206% | +$194K | 0.01% | 392 |
|
|
2021
Q3 | $104K | Buy |
+251
| New | +$104K | ﹤0.01% | 729 |
|
|
2020
Q3 | – | Sell |
-5,735
| Closed | -$1M | – | 1239 |
|
|
2020
Q2 | $1M | Buy |
+5,735
| New | +$1M | 0.11% | 211 |
|
|
2020
Q1 | – | Sell |
-1,946
| Closed | -$297K | – | 1025 |
|
|
2019
Q4 | $297K | Buy |
+1,946
| New | +$297K | 0.07% | 224 |
|
|
2019
Q3 | – | Sell |
-934
| Closed | -$133K | – | 1055 |
|
|
2019
Q2 | $133K | Buy |
+934
| New | +$133K | 0.04% | 423 |
|
|
2017
Q3 | – | Sell |
-141
| Closed | -$14K | – | 844 |
|
|
2017
Q2 | $14K | Sell |
141
-227
| -62% | -$22.5K | 0.01% | 419 |
|
|
2017
Q1 | $33K | Sell |
368
-5,634
| -94% | -$505K | 0.04% | 316 |
|
|
2016
Q4 | $457K | Buy |
+6,002
| New | +$457K | 0.46% | 49 |
|
|
2016
Q1 | – | Sell |
-86
| Closed | -$7K | – | 533 |
|
|
2015
Q4 | $7K | Buy |
+86
| New | +$7K | 0.02% | 311 |
|
|
2015
Q3 | – | Sell |
-1,388
| Closed | -$98K | – | 133 |
|
|
2015
Q2 | $98K | Sell |
1,388
-600
| -30% | -$42.4K | 0.19% | 93 |
|
|
2015
Q1 | $158K | Buy |
1,988
+1,126
| +131% | +$89.5K | 0.14% | 112 |
|
|
2014
Q4 | $55K | Buy |
862
+737
| +590% | +$47K | 0.05% | 385 |
|
|
2014
Q3 | $7K | Buy |
+125
| New | +$7K | ﹤0.01% | 317 |
|